Iain McGregor - Publications

Psychology University of Sydney, Camperdown, New South Wales, Australia 

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gamage TF, Barrus DG, Kevin RC, Finlay DB, Lefever TW, Patel PR, Grabenauer MA, Glass M, McGregor IS, Wiley JL, Thomas BF. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018. Pharmacology, Biochemistry, and Behavior. 172918. PMID 32247816 DOI: 10.1016/J.Pbb.2020.172918  0.312
2018 Everett NA, McGregor IS, Baracz SJ, Cornish JL. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement. Neuropharmacology. PMID 29353054 DOI: 10.1016/j.neuropharm.2017.12.036  0.417
2017 Kevin RC, Wood KE, Stuart J, Mitchell AJ, Moir M, Banister SD, Kassiou M, McGregor IS. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA. Journal of Psychopharmacology (Oxford, England). 269881116684336. PMID 28093016 DOI: 10.1177/0269881116684336  0.375
2016 Ramos L, Hicks C, Caminer A, Couto K, Narlawar R, Kassiou M, McGregor IS. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors. Pharmacology, Biochemistry, and Behavior. PMID 27725273 DOI: 10.1016/J.Pbb.2016.10.002  0.623
2016 Hicks C, Ramos L, Dampney B, Baracz SJ, McGregor IS, Hunt GE. Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059. Brain Research Bulletin. PMID 27725169 DOI: 10.1016/J.Brainresbull.2016.10.005  0.627
2015 Baracz SJ, Parker LM, Suraev AS, Everett NA, Goodchild AK, McGregor IS, Cornish JL. Chronic methamphetamine self-administration dysregulates oxytocin plasma levels and oxytocin receptor fibre density in the nucleus accumbens core and subthalamic nucleus of the rat. Journal of Neuroendocrinology. PMID 26563756 DOI: 10.1111/Jne.12337  0.307
2015 Ramos L, Hicks C, Caminer A, Goodwin J, McGregor IS. Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Psychopharmacology. 232: 2631-41. PMID 25772337 DOI: 10.1007/S00213-015-3899-9  0.546
2015 Hicks C, Ramos L, Reekie TA, Narlawar R, Kassiou M, McGregor IS. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology. 232: 2659-67. PMID 25761839 DOI: 10.1007/S00213-015-3902-5  0.581
2014 Hicks C, Cornish JL, Baracz SJ, Suraev A, McGregor IS. Adolescent pre-treatment with oxytocin protects against adult methamphetamine-seeking behavior in female rats. Addiction Biology. PMID 25402719 DOI: 10.1111/Adb.12197  0.62
2014 Baracz SJ, Everett NA, McGregor IS, Cornish JL. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats. Addiction Biology. PMID 25399704 DOI: 10.1111/adb.12198  0.416
2014 van Nieuwenhuijzen PS, McGregor IS, Chebib M, Hunt GE. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382. Neuroscience. 277: 700-15. PMID 25088910 DOI: 10.1016/j.neuroscience.2014.07.056  0.407
2014 Ramos L, Hicks C, Caminer A, McGregor IS. Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats. Psychoneuroendocrinology. 46: 46-51. PMID 24882157 DOI: 10.1016/J.Psyneuen.2014.04.013  0.631
2014 Bowen MT, McGregor IS. Oxytocin and vasopressin modulate the social response to threat: a preclinical study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1621-33. PMID 24807123 DOI: 10.1017/S1461145714000388  0.358
2014 Wong A, Keats K, Rooney K, Hicks C, Allsop DJ, Arnold JC, McGregor IS. Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences. Psychopharmacology. 231: 3987-96. PMID 24696079 DOI: 10.1007/S00213-014-3532-3  0.527
2014 Hicks C, Ramos L, Reekie T, Misagh GH, Narlawar R, Kassiou M, McGregor IS. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. British Journal of Pharmacology. 171: 2868-87. PMID 24641248 DOI: 10.1111/Bph.12613  0.603
2014 Suraev AS, Bowen MT, Ali SO, Hicks C, Ramos L, McGregor IS. Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood. Hormones and Behavior. 65: 488-96. PMID 24631584 DOI: 10.1016/J.Yhbeh.2014.03.002  0.612
2014 Bruno R, Allsop DJ, Copeland J, Lintzeris N, McGregor I, Norberg M, Dunlop A, Montebello M, Sadler C, Holland R, Rivas G. The impact of Sativex® on cognitive function during treatment for cannabis withdrawal Drug and Alcohol Dependence. 140: e22. DOI: 10.1016/J.Drugalcdep.2014.02.082  0.37
2013 Motbey CP, Clemens KJ, Apetz N, Winstock AR, Ramsey J, Li KM, Wyatt N, Callaghan PD, Bowen MT, Cornish JL, McGregor IS. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. Journal of Psychopharmacology (Oxford, England). 27: 823-36. PMID 23739178 DOI: 10.1177/0269881113490325  0.334
2013 Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M, McGregor IS. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2249-59. PMID 23676791 DOI: 10.1038/Npp.2013.125  0.658
2013 Banister SD, Wilkinson SM, Longworth M, Stuart J, Apetz N, English K, Brooker L, Goebel C, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. Acs Chemical Neuroscience. 4: 1081-92. PMID 23551277 DOI: 10.1021/cn400035r  0.303
2012 Motbey CP, Karanges E, Li KM, Wilkinson S, Winstock AR, Ramsay J, Hicks C, Kendig MD, Wyatt N, Callaghan PD, McGregor IS. Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. Plos One. 7: e45473. PMID 23029034 DOI: 10.1371/Journal.Pone.0045473  0.598
2012 May MD, Bowen MT, McGregor IS, Timberlake W. Rubbings deposited by cats elicit defensive behavior in rats. Physiology & Behavior. 107: 711-8. PMID 22433389 DOI: 10.1016/J.Physbeh.2012.03.007  0.339
2012 Hicks C, Jorgensen W, Brown C, Fardell J, Koehbach J, Gruber CW, Kassiou M, Hunt GE, McGregor IS. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. Journal of Neuroendocrinology. 24: 1012-29. PMID 22420322 DOI: 10.1111/J.1365-2826.2012.02311.X  0.593
2012 Cornish JL, Hunt GE, Robins L, McGregor IS. Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience. 206: 100-14. PMID 22266344 DOI: 10.1016/j.neuroscience.2012.01.004  0.334
2012 Baracz SJ, Rourke PI, Pardey MC, Hunt GE, McGregor IS, Cornish JL. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behavioural Brain Research. 228: 185-93. PMID 22155611 DOI: 10.1016/j.bbr.2011.11.038  0.402
2012 Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addiction Biology. 17: 409-22. PMID 21995495 DOI: 10.1111/j.1369-1600.2011.00384.x  0.382
2011 Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. Plos One. 6: e27237. PMID 22110618 DOI: 10.1371/journal.pone.0027237  0.391
2011 Hunt GE, McGregor IS, Cornish JL, Callaghan PD. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Research Bulletin. 86: 65-73. PMID 21745546 DOI: 10.1016/j.brainresbull.2011.06.011  0.321
2011 Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology. 218: 443-57. PMID 21667074 DOI: 10.1007/s00213-011-2342-0  0.377
2011 Verty AN, Evetts MJ, Crouch GJ, McGregor IS, Stefanidis A, Oldfield BJ. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1349-58. PMID 21412227 DOI: 10.1038/npp.2011.19  0.759
2010 Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, Boucher AA, McGregor IS. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addiction Biology. 15: 448-63. PMID 20731630 DOI: 10.1111/j.1369-1600.2010.00247.x  0.397
2010 van Nieuwenhuijzen PS, Long LE, Hunt GE, Arnold JC, McGregor IS. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology. 212: 663-74. PMID 20730418 DOI: 10.1007/s00213-010-1986-5  0.348
2010 Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor IS. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology. 58: 38-43. PMID 19560473 DOI: 10.1016/j.neuropharm.2009.06.018  0.376
2009 van Nieuwenhuijzen PS, Li KM, Hunt GE, McGregor IS. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats. Neuropsychobiology. 60: 195-203. PMID 19893336 DOI: 10.1159/000253555  0.355
2009 Gunasekaran N, Long LE, Dawson BL, Hansen GH, Richardson DP, Li KM, Arnold JC, McGregor IS. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. British Journal of Pharmacology. 158: 1330-7. PMID 19681888 DOI: 10.1111/j.1476-5381.2009.00399.x  0.317
2009 Verty AN, Boon WM, Mallet PE, McGregor IS, Oldfield BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16. PMID 19490094 DOI: 10.1111/j.1460-9568.2009.06750.x  0.784
2008 Thompson MR, Callaghan PD, Hunt GE, McGregor IS. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 1013-21. PMID 18302974 DOI: 10.1016/j.pnpbp.2008.01.014  0.377
2008 Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1113-26. PMID 17581536 DOI: 10.1038/sj.npp.1301475  0.701
2007 Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience. 146: 509-14. PMID 17383105 DOI: 10.1016/j.neuroscience.2007.02.032  0.321
2007 Chan-Ling T, Hughes S, Baxter L, Rosinova E, McGregor I, Morcos Y, van Nieuwenhuyzen P, Hu P. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation (New York, N.Y. : 1994). 14: 63-76. PMID 17365662 DOI: 10.1080/10739680601073451  0.319
2007 Clemens KJ, Cornish JL, Hunt GE, McGregor IS. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug and Alcohol Dependence. 86: 183-90. PMID 16884865 DOI: 10.1016/j.drugalcdep.2006.06.004  0.38
2006 Clemens KJ, Cornish JL, Hunt GE, McGregor IS. Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. Pharmacology, Biochemistry, and Behavior. 85: 454-63. PMID 17112571 DOI: 10.1016/j.pbb.2006.09.015  0.325
2006 O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology (Oxford, England). 20: 611-21. PMID 16714325 DOI: 10.1177/0269881106065188  0.74
2006 Singh ME, McGregor IS, Mallet PE. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 58-69. PMID 15920503 DOI: 10.1038/Sj.Npp.1300770  0.811
2005 Young JM, McGregor IS, Mallet PE. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1475-82. PMID 16178074 DOI: 10.1038/Sj.Npp.1300692  0.73
2005 Singh ME, McGregor IS, Mallet PE. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology. 49: 1189-200. PMID 16137723 DOI: 10.1016/J.Neuropharm.2005.07.008  0.813
2005 Verty AN, McGregor IS, Mallet PE. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9. PMID 16098995 DOI: 10.1016/J.Neuropharm.2005.03.025  0.82
2005 McGregor IS, Dam KD, Mallet PE, Gallate JE. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 35-45. PMID 15550450 DOI: 10.1093/Alcalc/Agh113  0.744
2004 O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology (Oxford, England). 18: 502-8. PMID 15582916 DOI: 10.1177/0269881104047277  0.778
2004 Singh ME, Verty AN, Price I, McGregor IS, Mallet PE. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69. PMID 15567425 DOI: 10.1016/J.Neuropharm.2004.08.008  0.789
2004 Morley KC, Cornish JL, Li KM, McGregor IS. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats. Pharmacology, Biochemistry, and Behavior. 79: 331-42. PMID 15501310 DOI: 10.1016/j.pbb.2004.08.004  0.352
2004 Singh ME, Verty AN, McGregor IS, Mallet PE. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research. 1026: 244-53. PMID 15488486 DOI: 10.1016/J.Brainres.2004.08.027  0.792
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 47: 593-603. PMID 15380376 DOI: 10.1016/J.Neuropharm.2004.06.002  0.804
2004 Verty AN, McGregor IS, Mallet PE. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Research. 1020: 188-95. PMID 15312802 DOI: 10.1016/J.Brainres.2004.06.033  0.817
2004 Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. Neuropharmacology. 46: 954-65. PMID 15081792 DOI: 10.1016/J.Neuropharm.2004.01.002  0.712
2004 Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology. 145: 3224-31. PMID 15033920 DOI: 10.1210/En.2004-0059  0.809
2004 Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology. 173: 318-25. PMID 15029472 DOI: 10.1007/s00213-004-1786-x  0.323
2004 Verty AN, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354: 217-20. PMID 14700735 DOI: 10.1016/J.Neulet.2003.10.035  0.798
2004 Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology. 173: 210-6. PMID 14663553 DOI: 10.1007/S00213-003-1694-5  0.732
2004 Thompson MR, Li KM, Clemens KJ, Gurtman CG, Hunt GE, Cornish JL, McGregor IS. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 694-704. PMID 14627999 DOI: 10.1038/sj.npp.1300347  0.334
2003 Verty AN, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168: 314-23. PMID 12700881 DOI: 10.1007/S00213-003-1451-9  0.795
2003 Norwood CS, Cornish JL, Mallet PE, McGregor IS. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. European Journal of Pharmacology. 465: 105-14. PMID 12650839 DOI: 10.1016/S0014-2999(03)01455-9  0.76
2003 Allen KV, McGregor IS, Hunt GE, Singh ME, Mallet PE. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. Neuropharmacology. 44: 264-74. PMID 12623225 DOI: 10.1016/S0028-3908(02)00364-7  0.814
2001 Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology. 433: 91-9. PMID 11755138 DOI: 10.1016/S0014-2999(01)01512-6  0.718
2001 Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Research. 921: 240-55. PMID 11720732 DOI: 10.1016/S0006-8993(01)03127-4  0.736
1999 Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology. 370: 233-40. PMID 10334497 DOI: 10.1016/S0014-2999(99)00170-3  0.745
1997 Lin HQ, Jackson DM, Atrens DM, Christie MJ, McGregor IS. Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. Brain Research. 744: 351-7. PMID 9027397 DOI: 10.1016/S0006-8993(96)01210-3  0.304
1996 McGregor IS, Dastur FN, McLellan RA, Brown RE. Cannabinoid modulation of rat pup ultrasonic vocalizations. European Journal of Pharmacology. 313: 43-9. PMID 8905327 DOI: 10.1016/0014-2999(96)00511-0  0.511
1996 McGregor IS, Issakidis CN, Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacology, Biochemistry, and Behavior. 53: 657-64. PMID 8866969  0.303
1994 McGregor IS, Lee AM, Westbrook RF. Stress-induced changes in respiratory quotient, energy expenditure and locomotor activity in rats: effects of midazolam. Psychopharmacology. 116: 475-82. PMID 7701052 DOI: 10.1007/BF02247481  0.307
Show low-probability matches.